Resources

This fact sheet explains how My Aged Care user should prepare for the phasing out of AUSkey at the end of March 2020.

These schemes for the viability supplement apply to some older residential aged care services.

This fact sheet is for residential aged care providers. Follow the steps to work out the number of points for your service under the 2017 scheme, to see whether you're eligible for the viability supplement.

This user guide is for Aged Care Assessment Teams (ACAT). It describes and explains how to use the ACAT Guidance Framework.

This guidance is for Aged Care Assessment Teams (ACAT). It informs and supports their decision making when recommending a high priority for a Home Care Package.

Natural Therapies Review Expert Advisory Panel (NTREAP) meeting outcomes for 28 November 2019 meeting.

The Aged Care Financing Authority (ACFA) looked at the financial impact of improving payment arrangements in home care. They provided this report to Government on 11 December 2019.

This report forms part of the advice the Aged Care Financing Authority (ACFA) provided to the Australian Government on 11 December 2019. ACFA reviewed the financial impact of improving payment arrangements in home care.

The Chief Medical Officer has written to approximately 28,000 practitioners about new resources for prescribers to support care of people with dementia who live in residential aged care.

This guideline lists the 13 parameters you must address when applying to add a Trans-Aortic Valve Implantation (TAVI) device to the Prostheses List.

This resource helps aged care providers to consider the diverse characteristics and life experiences of older people. You can use this template to create a diversity plan that is tailored to the needs of your organisation and the people you provide services to.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Fabry disease.

Treating physicians use this application form to apply for a patient to access LSDP medication for Gaucher disease for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for Batten disease for the first time, or after a break.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for MPS VI.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for MPS IVA.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for MPS II.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for MPS I.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Pompe disease.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for paroxysmal nocturnal haemoglobinuria.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Batten disease.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for hereditary tyrosinaemia (type 1).

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Gaucher disease.

Service providers under the National Aboriginal and Torres Strait Islander Flexible Aged Care Program must follow exit requirements when reducing or ending their aged care services.

A summary of how service providers can apply for funding under the National Aboriginal and Torres Strait Islander Flexible Aged Care Program.